These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-005267-21 A RANDOMIZED PHASE II PREVENTION TRIAL IN SUBJECTS AT HIGH RISK FOR HORMONE NON RESPONSIVE BREAST CANCER not-yet-due
Completed, but no date 2005-001132-72 A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma. bad-data
Ongoing 2005-001503-19 CLINICAL AND BIOLOGICAL STUDY ON THE ADMINISTRATION OF THALIDOMIDE IN PATIENTS WITH PRIMARY CANCER OF THE LIVER not-yet-due
Completed, but no date 2005-004614-32 Randomized phase II trial of Budesonide Turbuhaler 800 micrograms/twice daily versus placebo in high-risk population with undetermined lung nodules detected at screening low dose CT scan bad-data
Completed, but no date 2005-005039-86 A phase II study of Pegylated Liposomal Doxorubicin PLD as preoperative treatment for elderly patients with locally advanced primary breast cancer. bad-data
Completed, but no date 2005-005046-39 A randomized phase II study to assess the activity and tolerability of two regimens of metronomic oral chemotherapy methotrexate plus cyclophosphamide and cyclophosphamide plus capecitabine combi... bad-data
Completed, but no date 2005-005048-19 A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer bad-data
Ongoing 2005-005775-15 Pilot phase II study of a combined immunotherapy protocol based on oral vaccination and direct intratumoral injection of Salmonella Typhi Ty21a Vivotif in metastatic cutaneous melanoma patients. not-yet-due
Completed, but no date 2006-000520-14 A PHASE II STUDY OF GW572016 LAPATINIBTM ON CELL PROLIFERATION IN HER-2/neu ErbB2 POSITIVE BREAST CANCER BEFORE SURGERY. bad-data
Ongoing 2006-002152-16 Phase II randomized study of intravenous bevacizumab with sequential versus concurrent oral vinorelbine plus capecitabine in patients with locally advanced or recurrent breast cancer with lymphangitic... not-yet-due
Completed, but no date 2006-002168-24 O6-alkylguanine-DNA-alkyltransferase modulation study Fotemustine plus Temozolomide phase I/II . bad-data
Ongoing 2006-002655-33 Safety evaluation of the i.v. administration of Visipaque in patients with myeloma or monoclonal gammopathy not-yet-due
Completed, but no date 2006-003495-35 PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROMムS MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY. bad-data
Ongoing 2006-004856-19 PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX), CISPLATINUM AND FLUOROURACIL AS CONTINUOUS INFUSION (CCF) IN LOCALLY not-yet-due
Ongoing 2006-005004-14 A phase II study about the use of intensified hybrid chemotherapy regimen ChLVVP/ABVVP in advanced Hodgkin lymphoma patients. not-yet-due
Ongoing 2006-005831-44 A new induction therapy (ThalDoDex) for multiple myeloma. A phase II study. not-yet-due
Completed, but no date 2006-006010-15 PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX), CISPLATINUM bad-data
Ongoing 2007-002059-18 A Phase II study evaluating intermittent letrozole as adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, early stage breast cancer not-yet-due
Completed, but no date 2007-002588-28 PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREAST bad-data
Ongoing 2007-003309-28 EFFECT OF MECHANICAL BOWEL PREPARATION WITH POLYETHYLENE GLYCOL PLUS BOWEL ENEMA (GLYCERIN 5%) VS BOWEL ENEMA ALONE IN PATIENTS CANDIDATES TO COLORECTAL RESECTION FOR MALIGNANCY. PROSPECTIVE RANDOMIZE... not-yet-due
Ongoing 2007-003856-12 PREvention of atrial fibrillation in patientS undergoing thorAcic surGEry for lung cance not-yet-due
Ongoing 2007-006025-27 A phase II study of metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with bevacizumab and erlotinib (BEXE), plus trastuzumab in HER2/neu positive tumors (BEXET), in advanc... not-yet-due
Ongoing 2007-006026-10 PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE ± TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER not-yet-due
Not reported 2007-006306-25 A phase II study of primary chemotherapy with pegylated liposomal doxorubicin (Caelyx), Cisplatin, and Fluorouracil (CCF) followed by metronomic Capecitabine, Cyclophosphamide and Sorafenib (CCS) in e... 2009-05-04 due-trials
Ongoing 2008-000341-64 EVALUATION OF ACQUIRED OVEREXPRESSION OF HER2/neu ON CIRCULATING TUMOR CELLS IN PATIENTS WITH ADVANCED BREAST CANCER DURING CHEMOTHERAPY, AND ASSESSMENT OF ACTIVITY OF TRASTUZUMAB-BASED THERAPY: A PHA... not-yet-due
Ongoing 2008-000688-41 IMATINIB MESYLATE IN ADVANCED LOW GRADE SOLID TUMORS EXPRESSING IMATINIB MESYLATE TARGETS not-yet-due
Completed, but no date 2008-002958-37 Differences in dynamic contrast-enhanced (DCE) MRI measurements using Magnevist (Gd-DTPA) and Vas-ovist in patients with untreated squamous cell cervical carcinoma. bad-data
Ongoing 2008-004169-25 Phase II study of Exemestane dose intensification (150 mg daily) in postmenopausal patients with advanced breast cancer progressing under standard dose Exe (25 mg daily) given as adjuvant or palliativ... not-yet-due
Completed, but no date 2008-004912-10 A pre-surgical phase II study on activity of Metformin on breast cancer cells proliferation. bad-data
Completed, but no date 2008-006262-28 Allogeneic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Refractory “Triple Negative” Br... bad-data
Ongoing 2008-006383-10 A phase II randomized study evaluating the role of 8 courses of primary chemotherapy versus 4 courses of primary chemotherapy in combination with endocrine therapy in locally advanced breast canc... not-yet-due
Ongoing 2009-009937-14 Metronomic Capecitabine plus Docetaxel as first line treatment for metastatic breast cancer patients: a phase II trial not-yet-due
Completed, but no date 2009-009938-33 Temozolomide in the chemo-immuno-therapy of refractory acute leukaemia of adult patients: The TRIAC protocol bad-data
Ongoing 2009-010260-41 Breast cancer prevention with fenretinide in young women at genetic and familial risk. A phase III randomized clinical trial not-yet-due
Ongoing 2009-012048-18 �Fase II study with epirubicin, cisplatin and infusional fluorouracil (ECF) followed by weekly paclitaxel plus metronomic cyclophosphamide � trastuzumab as preoperative treatment of locally advance... not-yet-due
Ongoing 2009-012049-46 Phase III, randomized, double blind trial on Vitamin D supplementation for resected stage II melanoma patients. not-yet-due
Completed, but no date 2009-014833-26 Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions. An Inter-Consortium Collaborative Study. bad-data
Ongoing 2009-016453-17 Phase II study of preoperative bevacizumab plus weekly paclitaxel, carboplatin and metronomic cyclophosphamide � trastuzumab and endocrine therapy for inflammatory breast cancer not-yet-due
Ongoing 2009-018083-94 Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression w... not-yet-due
Ongoing 2010-018519-14 Rituximab-2cda + Rituximab maintenance in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma not-yet-due
Ongoing 2010-020472-34 18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma not-yet-due
Ongoing 2010-020835-38 “A phase II study of cisplatin plus cyclophospamide for patients with previously treated, advanced, triple receptor negative breast cancer” not-yet-due
Ongoing 2010-021815-18 - Identification of the sentinel node in breast cancer with fluorescence lymphography using indocyanine green dye (ICG): pilot study. not-yet-due
Ongoing 2010-022183-12 Phase II study of metronomic oral Vinorelbine plus Bevacizumab as first line treatment for metastatic breast cancer patients not-yet-due
Completed, but no date 2010-022967-37 Bowel cleansing for colonoscopy: comparison between a same day low-volume preparation and a conventional split one. bad-data
Ongoing 2010-024266-21 A phase II study of metronomic oral chemotherapy with cyclophosphamide plus capecitabine and vinorelbine in metastatic breast cancer patients not-yet-due
Ongoing 2010-024603-26 A phase II study of low-dose vaginal estrogens in pre and postmenopausal breast cancer patients with urogenital atrophy not-yet-due
Ongoing 2011-002288-29 New frontiers in breast imaging: contrast enhanced digital mammography. - Clinical performance of contrast-enhanced spectral mammography (CESM - SenoBright) in pre-surgical evaluation of extent of m... not-yet-due
Ongoing 2011-002542-12 Lymphatic mapping in oropharyngeal neoplasms: comparison between Dynamic Lymphoscintigrafy and Fluorescence Lymphografy using indocyanine green dye (ICG). Validation study. not-yet-due
Ongoing 2011-005275-16 Radio-guided minimally invasive resection of early colon cancer not-yet-due
Ongoing 2012-001978-28 A Phase II study of intermittent letrozole plus transdermal estradiol gel 3 month-therapy as adjuvant endocrine treatment for postmenopausal women with hormone-receptor positive early stage breast c... not-yet-due
Ongoing 2012-002248-26 Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies. not-yet-due
Ongoing 2012-002765-36 SIB –IMRT using a modulated accelerated fractionation for head and neck cancer patients not-yet-due
Ongoing 2012-004489-17 WAVE: Weekly nab-paclitaxel (Abraxane®) Versus Epirubicin in women with early breast cancer who are elderly or unfit for a 3-weekly polychemotherapy regimen: a Phase II Randomized Trial evaluating Act... not-yet-due
Ongoing 2013-003336-72 A Phase IIb study of topic DAC-0060, a synthetic histone deacetylase inhibitor, plus Tazarotene in patients with cutaneous basal cell carcinoma (BCC) not-yet-due